Georgia pharma company recalls thyroid drug for super potency

Alpharetta, Ga.-based Acella Pharmaceuticals recalled 13 lots of NP Thyroid after finding the drug to be super potent.

NP Thyroid tablets, which treat underactive thyroid, consist of levothyroxine and liothyronine. After receiving two reports of adverse events, Acella tested the drug to find that it may have up to 115 percent of its labeled amount of liothyronine, which can cause overactive thyroid.

The negative effects of overactive thyroid include heat intolerance, weight loss, fatigue, muscle weakness, rapid heart rate and hypertension. Pregnant patients who may have consumed prescriptions from a superpotent lot are also at risk of miscarriage and fetal development impairment.

More articles on pharmacy:
WHO suspends hydroxychloroquine trial over safety concerns
Drugmakers worried about Washington's push to bring drug manufacturing back to US
Anti-anxiety drug prescriptions rise, spur addiction, abuse concerns

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers